FDA Orange Book · active-ingredient family
Ceftriaxone sodium; lidocaine
Ceftriaxone sodium; lidocaine is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:ROCEPHIN KIT · NDA 050585
1
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ROCEPHIN KIT×2 | HOFFMANN LA ROCHE | NDA 050585 | — | May 08, 1996 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Ceftriaxone sodium; lidocaine — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

